Analysts predict further growth of clinical trials in developing nations

Standard

Developing countries such as India may see a rise in the number of outsourced clinical trials. This prediction has come after the US Pharma giant Pfizer struck a path breaking deal with Parexel, a major player (CRO) in the contract research business. Parexel will provide the US major a range of clinical development service for the next five years. Pfizer also announced that Icon, another large CRO will also be involved in program initiation and management; site and country feasibility; data management and reporting set-up; program study drug logistics; scientific and medical communications; and quality assurance services for Pfizer.
Market analysts predict that this is just the beginning of the trend. Pfizer is not the first company to get into such an arrangement with contract research organizations. The US giant has just entered the race after Sanofi Aventis, GSK and Eli Lilly have struck similar deals. This is a planned strategy of pharma giants, considering the expected future plummet in profits, as many of the blockbuster drugs will lose patents in coming years. Spokesperson from Pfizer said, “Like all of our industry peers, Pfizer is challenged with insufficient productivity and an unsustainable model for innovation.” He added that: “We intend to create novel and flexible partnerships to externalize R&D services.”
Analysts further state that this is going to immediately increase the share of outsourcing from 41% to 49% and by the year 2015 we may see the figure rising up to about 80%. Most of Pharma industry will restrict themselves from R & D service and will land in similar partnerships. This is beneficial in long term for the drug development industry as well. The upcoming trends will certainly have an impact on the conduct of clinical trials, which are expected to increase in case of developing countries. Countries like India, China and Brazil would like to make the most of such opportunities. Given the present scenario with the changing regulatory environment, India can benefit itself the most. If India maintains quality in the conduct of clinical trials and follows ethical guidelines and regulations, the future certainly seems bright for the contract research business.

Share

Basics of Pharmacovigilance: A Quick Overview

Standard

The Indian Pharmaceutical industry is growing at a rate of 12-14% per annum. Now, India is emerging as a destination for Drug Discovery and Development and is a Global Hub for Clinical Trials. Rapid growth in pharmaceutical entities and clinical trials has thrown up challenges of monitoring Adverse Drug Reactions (ADRs) over the global population.
It is true that all medicines have side effects and it is important to monitor both known and unknown side effects of medicines to determine new information available for their safety profile. This safety profile is accessed with the help of Pharmacovigilance program. Hence, it is very important to have a standardized and robust Pharmacovigilance and drug safety monitoring program.

Continue reading

Share

Pharmacovigilance Training Courses in India

Standard

A number of people aspire to work in the area of pharmacovigilance, but do you really know what pharmacovigilance is all about, what it takes to be a good pharmacovigilance professional and what it takes to get into this sector? Well pharmacovigilance (abbreviated PV or PhV) is the pharmacological science relating to the detection, assessment, understanding and prevention of adverse effects, particularly long term and short term side effects of medicines. Almost all drug development companies have pharmacovigilance departments to cater to these requirements of the regulatory authorities. These drug development companies are supposed to maintain records of side effects of drugs that were reported during its development and even after the drug is available in the market. Every time an significant event is reported the same has to be forwarded to the regulatory authorities for evaluation. Throughout the course of drug development the pharmacovigilance teams also look for certain signals that may point out towards a certain potential toxic effect of the drug. All of you may have heard of certain drugs being taken off the market due to safety concerns. Such acts are possible only when proper pharmacovigilance systems are in place. Continue reading

Share

Hospital Administration Courses in India

Standard

With the growing number of hospitals in India there is a need for trained professionals in this field who have a good know how about the healthcare industry and an understanding of how hospital setups function at large. With increasing opportunities of employment the hospital management staff are looking for employable talent i.e. people who have the know how of the healthcare industry to be a part of their workforce. The growing number of jobs have resulted from the healthcare boom that the country is currently witnessing. Numerous private and government hospitals are coming up with each passing day to cater to the demand of a large country as India. A country with over a billion people. If you are a graduate in any subject and wish to make a career in this growing industry, enrolling in a program about healthcare and hospital administration is the first step you should take. This would not only enhance your knowledge about healthcare and hospital management but will also make you more employable in this sector. James Lind Institute takes pride in the healthcare and hospital management course that it offers which has been developed in association with the Global hospital chain to cater to the demand of this industry. The healthcare and hospital management diploma can be completed by any student within six months with flexible study times as the program is offered on an online platform. The students can log in any time they wish to study. To know more about the healthcare and hospital management diploma offered by us please feel free to visit this page: Advanced PG Diploma in Healthcare & Hospital Management

Share

Leveraging Social Media Networks for Clinical Trials – by Pharma & Biotech

Standard

Social media or networks are media for social interaction such as blogs, ratings and reviews,
podcasts and video between people who are connected by common attributes which are becoming progressively more important to businesses and organizations. Similar to their rising importance in other industries social media has a lot of applications with immense potential for the pharma industry. There are several strategies that pharma/biotech companies can implement to profit from the social media space in clinical trials such as for patient recruitment, post marketing drug safety apart from building brand, increasing market value etc. These can help pharma/biotech companies achieve their goals in clinical trials.

Continue reading

Share

Health Care: Quality Improvement of Tools

Standard

Quality of care in health systems is very wide-ranging and at the same time difficult to standardize. Depending on the corrective standard, quality can be understood in various ways, using different terms, labels and models, Quality of care in health systems is defined as “the degree to which health services for individuals and populations increase the likelihood of desired health outcomes and are consistent with current professional knowledge.”

“To err is human”, it is observed that majority of medical errors result from flawed system and processes, not individuals. A report from the Institute of Medicine (IOM), stressed on the improvement of the lower functional level of the present health care industry and put forth the following:…

Continue reading

Share